MedTrace Logo

A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

NCT01542580 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 255

Last updated 2025-11-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.

Conditions

Interventions

DEVICE

Vanguard SSK 360 with PS Bearing

non-constrained tibial bearing

DEVICE

Vanguard SSK 360 with PSC bearing

constrained tibial bearing

DEVICE

Vanguard DA 360

Dual-articulation device, only cleared in EU

DEVICE

Vanguard 360 TiNbN Femur with PS bearing

non-constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

DEVICE

Vanguard 360 TiNbN Femur with PSC bearing

constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Emilie Rohmer · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2031-12-31
Completion
2031-12-31

Countries

  • United States
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542580 on ClinicalTrials.gov